Commentary
| Rev Diabet Stud,
2005,
2(4):187-189 |
DOI 10.1900/RDS.2005.2.187 |
Limitations in Immunotherapy with CD3 Antibodies: Comment on the Article by Drs. Chatenoud and Bach
Damien Bresson, Matthias von Herrath
La Jolla Institute for Allergy and Immunology, Department of Developmental Immunology 3, 10355 Science Center Drive, San Diego, California 92121, USA.
Address correspondence to: Matthias von Herrath, e-mail: matthias@liai.org
Abstract
Fulltext:
 HTML
,  PDF
(174KB)
| Rev Diabet Stud,
2005,
2(4):190-191 |
DOI 10.1900/RDS.2005.2.190 |
Response to the Comment by D. Bresson and M. von Herrath
Lucienne Chatenoud, Jean-François Bach
Université René Descartes Paris 5, INSERM U580, Hôpital Necker-Enfants Malades, Paris, France.
Address correspondence to: Jean-François Bach, e-mail: bach@necker.fr
Abstract
Fulltext:
HTML
, PDF
(167KB)
|
